Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 149
| Title | Principal Investigator | Start Year | Funding Agency | Research Area |
|---|---|---|---|---|
| Preparation and Characterization of Novel Formulations of Nepafenac for the Management of Ocular Inflammation. | Mrs. Deepshikha, University Institute Of Pharmaceutical Sciences, Panjab University, Chandigarh (160014) | 2024 | Department of Science and Technology (DST) | Pharmaceutical Sciences |
| Substantiation of PI3K/Akt Signaling Pathway in Alzheimer’s disease employing Pharmacological Strategies and their Nano-formulations | Prof. Nitin Bansal, Chaudhary Bansi Lal University, Haryana | 2024 | Anusandhan National Research Foundation/ Science and Engineering Research Board | Pharmaceutical Sciences |
| NIR Light Controlled Activity Of Antibiotics By Using Upconversion Nanoparticles | Dr. Debasish Manna, Indian Institute of Science Education and Research (IISER) Bhopal, Madhya Pradesh | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Targeting peroxisomal fatty acid oxidation to overcome resistance to therapy in breast cancer cells | Dr. Sudhagar S, Assistant Professor, National Institute of Pharmaceutical Education and Research (NIPER-G), Guwahati | 2024 | Funding Agency: Anusandhan National Research Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Development of in vitro and in vivo drug screening platforms against the chikungunya virus | Dr. Chetan Dewaji Meshram, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh | 2024 | Anusandhan National Research Foundation/ Science and Engineering Research Board | Pharmaceutical Sciences |
| A Multiscale Study of Photoswitchable Drugs for Optimal Control of G-Protein Coupled Receptors | Dr. Padmabati Mondal, Indian Institute of Science Education and Research (IISER) Tirupati, Andhra Pradesh | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Determination of In Vivo Effective Diffusion Rates of Therapeutics from Controlled Release Systems | Dr. Siddharth Jhunjhunwala, Indian Institute Of Science, Bangalore, Karnataka | 2024 | Anusandhan National Rsearch Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| A clinical drug development programme to evaluate and compare the safety and efficacy of new regimens of Lifecare's Liposomal Amphotericin b (FUNGISOMETM) against currently accepted therapies for the treatment of Kala Azar; A Phase III, Open Label Randomized Trial of Three Single Dose Treatment regimens of FUNGISOMETM ALONE OR IN Combination with Miltefosine compared with single Dose Treatment regimen of AmBisome for visceral Leishmaniasis in India | Dr. J N Verma, Lifecare Innovations Private Limited, Gurgaon, Haryana (122018) | 2024 | Department of Science and Technology (DST) | Pharmaceutical Sciences |
| Stereoselective Synthesis of Structurally Diverse Sp3-rich Polycyclic Scaffolds: Generation of High valued New Molecular Entities (NMEs) for GPCR Modulators | Dr. Ravindra Kumar, CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh | 2024 | Anusandhan National Research Foundation (ANRF)/Science and Engineering Research Board (SERB) | Pharmaceutical Sciences |
| Molecular explorations of the Leishmania donovani Homoserine Dehydrogenase and evaluating the impact of its perturbations using CRISPR-Cas9 system’’ | Dr. Sushma Singh, Associate Professor, National Institute of Pharmaceutical Education and Research (NIPER), | 2023 | Pharmaceutical Sciences |